Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

instr__news

Webhose 2025 Dec 05, 22:05

Novavax, Inc. (NVAX): A Bull Case Theory

Novavax Inc
Webhose 2025 Dec 04, 07:12

Novavax (NVAX): Exploring Valuation After Prolonged Share Price Weakness

Novavax Inc
Webhose 2025 Dec 04, 01:27

Is Novavax Now a Bargain After a 94.1% Five Year Share Price Slump?

Novavax Inc
Webhose 2025 Dec 01, 17:09

Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino

Novavax Inc
Webhose 2025 Nov 28, 00:28

Novavax (NVAX) Valuation: Assessing the Shift to Partnerships and an R&D-Focused Strategy - Simply Wall St News

Novavax Inc
Webhose 2025 Nov 26, 18:25

Novavax call volume above normal and directionally bullish | Markets Insider

Novavax Inc
Webhose 2025 Nov 26, 03:11

What Recent Partnership Efforts Mean for the Value of Novavax in 2025

Novavax Inc
Webhose 2025 Nov 25, 13:39

Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast

Novavax Inc
Webhose 2025 Nov 21, 06:34

JPMorgan Chase & Co. Cuts Novavax (NASDAQ:NVAX) Price Target to $6.00 - Stock Observer

Novavax Inc
Webhose 2025 Nov 19, 16:16

JPMorgan Chase & Co. Issues Pessimistic Forecast for Novavax (NASDAQ:NVAX) Stock Price

Novavax Inc
Webhose 2025 Nov 19, 03:21

Novavax (NVAX): Evaluating Valuation Gaps as Shares Extend Recent Slide

Novavax Inc
Webhose 2025 Nov 18, 08:16

JPMorgan Chase & Co. Lowers Novavax (NASDAQ:NVAX) Price Target to $6.00 - Daily Political

Novavax Inc
Webhose 2025 Nov 17, 07:34

Analysts Set Novavax, Inc. (NASDAQ:NVAX) PT at $11.38 - Markets Daily

Novavax Inc
Webhose 2025 Nov 17, 05:52

Investment Analysts' Weekly Ratings Changes for Novavax (NVAX) - Stock Observer

Novavax Inc
Webhose 2025 Nov 15, 11:16

Jupiter Asset Management Ltd. Buys 582,858 Shares of Novavax, Inc. $NVAX

Novavax Inc
Webhose 2025 Nov 15, 06:54

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages

Novavax Inc

Novavax news

Latest news

Show more

Info

Spread

0.05

Spread (%)

0.7508 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

1067618432

instr__shares_outstand

162498995

instr__earnings_date

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

1.97

instrument_learn_more

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

related_instruments

Asset
Sell
Buy
Change (%)

trade_now_btn

trade_now_btn

trade_now_btn

trade_now_btn
view_all_instruments

latest_education_articles

Show more
Trustpilot